HB Human BioScience

HB Human BioScience is a privately held Latin American pharmaceutical company focused on licensing, distributing, developing, and commercializing medicines for rare, orphan, and catastrophic diseases. The company operates a hybrid model that includes expanded-access or named-patient supply, in-licensing of innovative and high-value products from global partners, and internal development of proprietary products for Latin American markets. Its portfolio and stated focus areas include oncology, leukemia, pulmonary arterial hypertension, transplant-related therapies, anti-infectives, and other specialty medicines. HB Human BioScience has regional operations centered in Colombia and has expanded into Peru, Ecuador, and Panama, with additional international links noted in the United States and India. Public materials indicate commercial activity, regulatory filings, and licensing deals rather than a classic venture-backed clinical-stage biotech pipeline.